Patient experience

future forward-looking 2026 new year
Biotech

Pharma's 'urgent need for reinvention': PwC's call to action

PwC has laid out bold ambitions for what it believes drugmakers could achieve by 2035, as well as steps those companies should start taking in 2026.
Fraiser Kansteiner Jan 8, 2026 6:00am